Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Impaired neuromotor function following cancer treatment can improve

09.11.2004


Patients who suffer a loss of cognitive and motor function as a result of stem cell transplantation for severe blood disorders are likely to see those functions return to previous levels after one year, according to a new study in the November 15, 2004, issue of Blood, the official journal of the American Society of Hematology.


Researchers from the Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine studied 142 patients who had blood disorders, such as chronic myeloid leukemia, myelodysplasia, and myelofibrosis, and who underwent hematopoietic cell transplant (a procedure to replace cancerous cells with new, healthy ones).

In preparation for the transplant, patients underwent high-dose chemotherapy to destroy their diseased bone marrow. Some of the drugs used for this purpose are known to have neurotoxic effects. In addition, medication to decrease the toxicity of the transplant to normal tissues, termed graft-versus-host disease (GVHD), may also lower neurocognitive function.

To test the extent of this type of damage, each patient’s cognitive and motor functions, such as problem solving, memory, motor speed and dexterity, attention, and word association, were tested before, 3 months after, and 1 year after the transplant. At three months after transplant, patients experienced a significant decline in all the functions tested. By one year, however, the neuromotor functions for most patients had come back to the level experienced before the transplant, with the exception of two capabilities: grip strength and motor dexterity.



The study also uncovered factors which lowered the risk of patients having impaired neuromotor function. Patients who had no chemotherapy or chemotherapy with only hydroxyurea prior to the transplant and those who did not receive certain immune suppressants (cyclosporine, tacrolimus, or mycophenolate mofetil) to ward off GVHD were better off.

At one year, 70 percent of patients were still receiving treatment for GVHD. Therefore, further improvement might be expected beyond one year as patients continue to recover and are able to discontinue medications.

"The results of this study have important implications for physicians and patients when they have choices about treatments for these diseases. The most immediate value is for patients and their families to know what they can expect after hematopoietic cell transplant," according to Karen Syrjala, Ph.D., head of biobehavorial sciences at the Fred Hutchinson Cancer Research Center and lead author of the study.

Laura Stark | EurekAlert!
Further information:
http://www.hematology.org

More articles from Health and Medicine:

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

nachricht NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>